| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated cardiac allograft vasculopathy after pediatric heart transplantation
|
Zablah, Jenny E.
|
|
|
17 |
11 |
p. 2983-2985
|
artikel
|
| 2 |
American Journal of Transplantation: Volume 17, Number 11, November 2017
|
|
|
|
17 |
11 |
p. i
|
artikel
|
| 3 |
Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function
|
Adams, A.B.
|
|
|
17 |
11 |
p. 2922-2936
|
artikel
|
| 4 |
Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study
|
Bertrand, D.
|
|
|
17 |
11 |
p. 2937-2944
|
artikel
|
| 5 |
Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes
|
Adam, B.A.
|
|
|
17 |
11 |
p. 2841-2850
|
artikel
|
| 6 |
Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection
|
Chun, N.
|
|
|
17 |
11 |
p. 2810-2819
|
artikel
|
| 7 |
Comprehensive Review on Colorectal Cancer and Transplant
|
Prenner, S.
|
|
|
17 |
11 |
p. 2761-2774
|
artikel
|
| 8 |
Cutaneous Toxicities From Transplantation-Related Medications
|
Ilyas, M.
|
|
|
17 |
11 |
p. 2782-2789
|
artikel
|
| 9 |
Deciphering Tacrolimus-Induced Toxicity in Pancreatic β Cells
|
Triñanes, J.
|
|
|
17 |
11 |
p. 2829-2840
|
artikel
|
| 10 |
Diagnosing Cardiac Rejection
|
Pullen, Lara C.
|
|
|
17 |
11 |
p. 2751-2752
|
artikel
|
| 11 |
Direct-acting antiviral agent–based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study
|
Dharancy, Sébastien
|
|
|
17 |
11 |
p. 2869-2878
|
artikel
|
| 12 |
Donor-derived hepatitis C transmission from NAT negative donors–Still an unexpected event!
|
Wolfe, Cameron R.
|
|
|
17 |
11 |
p. 2989
|
artikel
|
| 13 |
Erratum
|
|
|
|
17 |
11 |
p. 2993
|
artikel
|
| 14 |
HCV-Positive Donor Organs in Solid Organ Transplantation: “Mind the Gap!”
|
Fishman, J.A.
|
|
|
17 |
11 |
p. 2755-2756
|
artikel
|
| 15 |
HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?
|
Martini, S.
|
|
|
17 |
11 |
p. 2986-2987
|
artikel
|
| 16 |
Hyperfiltration After Donation and Living Kidney Donor Risk
|
van Londen, M.
|
|
|
17 |
11 |
p. 2991
|
artikel
|
| 17 |
Invited response to “Hyperfiltration After Donation and Living Kidney Donor Risk”
|
Steiner, R.W.
|
|
|
17 |
11 |
p. 2992
|
artikel
|
| 18 |
Liver transplantation equity: Supply, demand, and access
|
Axelrod, David
|
|
|
17 |
11 |
p. 2759-2760
|
artikel
|
| 19 |
Living Donor Liver Transplantation for Patients Older Than Age 70 Years: A Single-Center Experience
|
Kwon, J.H.
|
|
|
17 |
11 |
p. 2890-2900
|
artikel
|
| 20 |
Living Donor Uterus Transplantation: A Single Center’s Observations and Lessons Learned From Early Setbacks to Technical Success
|
Testa, G.
|
|
|
17 |
11 |
p. 2901-2910
|
artikel
|
| 21 |
Making Therapeutic Antibodies in Vitro
|
Alegre, Maria-Luisa
|
|
|
17 |
11 |
p. 2753
|
artikel
|
| 22 |
Maximizing Utilization of the Donor Pool by Appropriate Classification of Hepatitis C Antibody-Positive Donors
|
Anesi, J.A.
|
|
|
17 |
11 |
p. 2757-2758
|
artikel
|
| 23 |
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants
|
Chandran, S.
|
|
|
17 |
11 |
p. 2945-2954
|
artikel
|
| 24 |
Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2017–18 Influenza Season
|
Grohskopf, L.A.
|
|
|
17 |
11 |
p. 2970-2982
|
artikel
|
| 25 |
Rat Hindlimb Cryopreservation and Transplantation: A Step Toward “Organ Banking”
|
Arav, A.
|
|
|
17 |
11 |
p. 2820-2828
|
artikel
|
| 26 |
Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study
|
Halloran, P.F.
|
|
|
17 |
11 |
p. 2851-2862
|
artikel
|
| 27 |
Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?
|
Levitsky, J.
|
|
|
17 |
11 |
p. 2988
|
artikel
|
| 28 |
Response to: Prophylactic Ureteric Stents in Renal Transplant Recipients: A Multicenter Randomized Controlled Trial of Early Versus Late Removal
|
Richards, J.A.
|
|
|
17 |
11 |
p. 2990
|
artikel
|
| 29 |
Risk of Thyroid Cancer Among Solid Organ Transplant Recipients
|
Kitahara, C.M.
|
|
|
17 |
11 |
p. 2911-2921
|
artikel
|
| 30 |
Social media and organ donation: Ethically navigating the next frontier
|
Henderson, M.L.
|
|
|
17 |
11 |
p. 2803-2809
|
artikel
|
| 31 |
Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients
|
Ross, K.
|
|
|
17 |
11 |
p. 2879-2889
|
artikel
|
| 32 |
Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management
|
Griffith, J.J.
|
|
|
17 |
11 |
p. 2775-2781
|
artikel
|
| 33 |
Splenic Vein Thrombosis Following Pancreas Transplantation: Identification of Factors That Support Conservative Management
|
Harbell, J.W.
|
|
|
17 |
11 |
p. 2955-2962
|
artikel
|
| 34 |
Successful Treatment of Kaposi Sarcoma–Associated Herpesvirus Inflammatory Cytokine Syndrome After Kidney–Liver Transplant: Correlations With the Human Herpesvirus 8 miRNome and Specific T Cell Response
|
Mularoni, A.
|
|
|
17 |
11 |
p. 2963-2969
|
artikel
|
| 35 |
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation
|
Levitsky, J.
|
|
|
17 |
11 |
p. 2790-2802
|
artikel
|
| 36 |
Utilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for Change
|
Kling, C.E.
|
|
|
17 |
11 |
p. 2863-2868
|
artikel
|
Tijdschrift beschrijving